Literature DB >> 17406941

Association of HLA class II genes with idiopathic pulmonary arterial hypertension in Koreans.

Sung-Ho Yoon1, Heung-Bum Oh, Hyun-Kuk Kim, Suk-Chan Hong, Yeon-Mok Oh, Dong Soon Lee, Sang-Do Lee.   

Abstract

The aim of this study was to compare the frequency of the HLA-DRB1 and HLA-DQB1 alleles in Korean patients with idiopathic pulmonary arterial hypertension (IPAH) and in normal controls and to determine any association that may exist between clinical characteristics of IPAH and specific HLA alleles. IPAH patients seen between October 1998 and September 2001 were retrospectively assessed, and 19 patients and 193 controls were HLA typed at the HLA-DRB1 and DQB1 loci. Clinical characteristics and hemodynamic parameters were reviewed. The patients with IPAH had a significantly higher frequency of the HLA-DRB1*0406 allele (18% vs. 6%, p = 0.004) and the HLA-DQB1*0302 allele (24% vs. 12%, p = 0.034), as well as a significantly higher frequency of haplotype DRB1*0406-DQB1*0302 (p = 0.0006). All 6 patients with haplotype DRB1*0406-DQB1*0302 (H+ group) were women, compared with 8 of the 13 patients lacking the DRB1*0406-DQB1*0302 haplotype (H- group), but without statistical significance. Three of 19 patients showed a positive short-term hemodynamic response to NO inhalation, all 3 of whom had the DRB1*0406-DQB1*0302 haplotype. There were no other significant differences in clinical characteristics and hemodynamic parameters between the H+ and H- groups. We conclude from this study that the HLA-DRB1*0406-DQB1*0302 haplotype is associated with IPAH in Korean patients. These results suggest that certain clinical characteristics of IPAH may be controlled in part by patients' HLA alleles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406941     DOI: 10.1007/s00408-007-9006-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  19 in total

1.  HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.

Authors:  P Langevitz; D Buskila; D D Gladman; G A Darlington; V T Farewell; P Lee
Journal:  Br J Rheumatol       Date:  1992-09

2.  Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku.

Authors:  R A Isern; M Yaneva; E Weiner; A Parke; N Rothfield; D Dantzker; S Rich; F C Arnett
Journal:  Am J Med       Date:  1992-09       Impact factor: 4.965

Review 3.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

4.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.

Authors:  J H Newman; L Wheeler; K B Lane; E Loyd; R Gaddipati; J A Phillips; J E Loyd
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

6.  Association of clinical features with HLA in chronic pulmonary thromboembolism.

Authors:  N Tanabe; A Kimura; S Amano; O Okada; Y Kasahara; K Tatsumi; M Takahashi; H Shibata; M Yasunami; T Kuriyama
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

7.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

8.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.

Authors:  J M Baisch; T Weeks; R Giles; M Hoover; P Stastny; J D Capra
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

10.  Antinuclear antibodies in primary pulmonary hypertension.

Authors:  S Rich; K Kieras; K Hart; B M Groves; J D Stobo; B H Brundage
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

View more
  2 in total

1.  HLA and Disease Associations in Koreans.

Authors:  Stephen Ahn; Hee-Back Choi; Tai-Gyu Kim
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

Review 2.  A systematic review of genetic mutations in pulmonary arterial hypertension.

Authors:  Gerardo Garcia-Rivas; Carlos Jerjes-Sánchez; David Rodriguez; José Garcia-Pelaez; Victor Trevino
Journal:  BMC Med Genet       Date:  2017-08-02       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.